Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, January 2001, p. 96-104, Vol. 45, No. 1
Stratton Veterans Affairs Medical Center and
Albany Medical College, Albany, New York
Received 7 April 2000/Returned for modification 9 June
2000/Accepted 13 October 2000
This study evaluates the effects of cytokines, used singly and in
combination, on the microbicidal activity of human monocyte-derived macrophages (MDM) against intracellular Candida albicans in
the presence and absence of fluconazole. In the absence of fluconazole, the addition of tumor necrosis factor alpha (TNF-
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.1.96-104.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Effects of Cytokines and Fluconazole on the
Activity of Human Monocytes against Candida
albicans
), interleukin-1
(IL-1
), gamma interferon (IFN-
), or IL-4 had no effect on the growth of C. albicans. In contrast, the addition of
granulocyte-macrophage colony-stimulating factor (GM-CSF) resulted in
decreased growth (P < 0.05), while the addition of
IL-10 resulted in increased growth (P < 0.01). In the
presence of fluconazole, only the addition of IFN-
resulted in an
increase in the growth of C. albicans. In the presence or
absence of fluconazole, all cytokine combinations except IFN-
plus
GM-CSF caused significant decreases in growth (P < 0.01). IL-10 and IL-4 did not influence the activity of TNF-
or
IL-1
. In the absence or presence of C. albicans the
addition of fluconazole, all of the cytokines studied, and combinations of fluconazole and selected cytokines caused increases in nitric oxide
(NO) production (P < 0.01). Similar observations were
made for superoxide (O2
) only in the presence
of C. albicans. The greatest concentrations of NO and
O2
were produced when C. albicans
alone was present in the assays. Our results demonstrate that in the
presence of low concentrations of fluconazole (0.1 times the MIC),
selected cytokines and their combinations significantly increase the
microbicidal activity of MDM against intracellular C. albicans.
*
Corresponding author. Mailing address: Infectious
Disease Research, Stratton VA Medical Center, Albany, NY 12208. Phone:
(518) 462-3311, ext. 3080. Fax: (518) 462-3350. E-mail:
BALTCH.ALDONA_{at}ALBANY.VA.GOV.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»